LIDOCAINE HYDROCHLORIDE ANHYDROUS

LIDOCAINE HYDROCHLORIDE ANHYDROUS was reported 7046 times

LIDOCAINE HYDROCHLORIDE ANHYDROUS is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DEVICE WIRELESS COMMUNICATION ISSUE 68 0.2625
1 REMOVAL OF FOREIGN BODY 22 0.2391
2 TRACHEAL DEVIATION 18 0.2045
3 SCHIZENCEPHALY 8 0.1778
4 DEVICE MAINTENANCE ISSUE 98 0.1667
5 UNEVALUABLE DEVICE ISSUE 13 0.1461
6 CEREBRAL HAEMORRHAGE FOETAL 8 0.1311
7 INFUSION SITE INJURY 23 0.1307
8 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 136 0.1281
9 INFUSION SITE DRYNESS 6 0.1111
10 VASCULAR MALFORMATION 20 0.0952
11 SULPHAEMOGLOBINAEMIA 11 0.0948
12 PHRENIC NERVE PARALYSIS 19 0.0868
13 INFUSION SITE DISCHARGE 145 0.0826
14 PARANASAL CYST 20 0.0823
15 INFUSION SITE SCAB 10 0.0813
16 INFUSION SITE STREAKING 7 0.0805
17 INFUSION SITE IRRITATION 100 0.0778
18 INFUSION SITE INDURATION 112 0.0755
19 TRIGEMINO-CARDIAC REFLEX 6 0.0741
20 INFUSION SITE INFLAMMATION 52 0.0737
21 INFUSION SITE HAEMORRHAGE 233 0.0708
22 INFUSION SITE WARMTH 86 0.0701
23 ADMINISTRATION SITE ODOUR 5 0.0658
24 INFUSION SITE NODULE 63 0.0656
25 INFUSION SITE INFECTION 150 0.0645
26 PATIENT DISSATISFACTION WITH DEVICE 16 0.0635
27 INFUSION SITE DISCOLOURATION 55 0.0625
28 INFUSION SITE PAIN 792 0.0614
29 INSPIRATORY CAPACITY DECREASED 17 0.0614
30 BODY TINEA 34 0.0607
31 INFUSION SITE ERYTHEMA 494 0.0585
32 INFUSION SITE HYPERSENSITIVITY 7 0.0583
33 ANAL INFLAMMATION 36 0.0563
34 DEVICE INFUSION ISSUE 137 0.0552
35 INFUSION SITE SWELLING 345 0.0548
36 INFUSION SITE CELLULITIS 27 0.0511
37 SARS-COV-2 TEST NEGATIVE 32 0.0474
38 GENITAL EROSION 14 0.0471
39 ACUTE MACULAR NEURORETINOPATHY 8 0.0468
40 INFUSION SITE DISCOMFORT 43 0.0415
41 ADMINISTRATION RELATED REACTION 8 0.0410
42 CANDIDA ENDOPHTHALMITIS 5 0.0410
43 INFUSION SITE REACTION 113 0.0378
44 SLEEP DISORDER THERAPY 7 0.0354
45 MATERNAL EXPOSURE DURING DELIVERY 34 0.0343
46 APPENDICOLITH 13 0.0336
47 INFUSION SITE PRURITUS 105 0.0332
48 INFUSION SITE VESICLES 17 0.0323
49 INFUSION SITE MASS 35 0.0322
50 CENTRAL PAIN SYNDROME 8 0.0302
51 INFUSION SITE RASH 40 0.0291
52 TONGUE SPASM 9 0.0288
53 BILE ACIDS INCREASED 5 0.0282
54 ANALGESIC THERAPY 9 0.0280
55 INFUSION SITE SCAR 12 0.0271
56 PAINFUL EJACULATION 6 0.0265
57 ADULTERATED PRODUCT 5 0.0250
58 PNEUMOCEPHALUS 8 0.0242
59 CATHETER SITE IRRITATION 8 0.0240
60 INFUSION SITE ABSCESS 12 0.0238
61 DEVICE POWER SOURCE ISSUE 69 0.0236
62 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 13 0.0232
63 INFUSION SITE BRUISING 50 0.0231
64 DEVICE ALARM ISSUE 42 0.0231
65 PROSTATIC PAIN 9 0.0221
66 BLOOD CHOLINESTERASE DECREASED 6 0.0219
67 MASTOIDITIS 21 0.0214
68 FOETAL EXPOSURE DURING DELIVERY 14 0.0206
69 INHIBITORY DRUG INTERACTION 32 0.0202
70 METHAEMOGLOBINAEMIA 43 0.0186
71 NEUROLOGIC NEGLECT SYNDROME 10 0.0180
72 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 18 0.0179
73 DRUG THERAPY 6 0.0177
74 TOXIC ANTERIOR SEGMENT SYNDROME 18 0.0165
75 DEVICE CONNECTION ISSUE 33 0.0156
76 PURULENT DISCHARGE 66 0.0154
77 MUCOSAL EROSION 14 0.0154
78 INFECTION SUSCEPTIBILITY INCREASED 32 0.0146
79 DEVICE ELECTRICAL FINDING 10 0.0141
80 PROCEDURAL HYPOTENSION 12 0.0141
81 EMBOLIA CUTIS MEDICAMENTOSA 11 0.0138
82 FOREIGN BODY IN RESPIRATORY TRACT 18 0.0137
83 SPINAL CORD INFARCTION 6 0.0136
84 INFUSION SITE URTICARIA 9 0.0134
85 PARTIAL SEIZURES WITH SECONDARY GENERALISATION 6 0.0128
86 MECHANICAL URTICARIA 6 0.0128
87 OPEN FRACTURE 6 0.0124
88 HYPOPROTEINAEMIA 23 0.0121
89 INFUSION SITE OEDEMA 10 0.0120
90 INFANTILE APNOEA 9 0.0110
91 HYPERTHERMIA MALIGNANT 16 0.0107
92 CATHETER SITE SWELLING 10 0.0107
93 ANAPHYLACTOID SHOCK 5 0.0106
94 CAROTID ARTERY THROMBOSIS 9 0.0106
95 INFUSION SITE HAEMATOMA 5 0.0105
96 CAUDA EQUINA SYNDROME 8 0.0104
97 EXTRADURAL ABSCESS 8 0.0102
98 ANAESTHETIC COMPLICATION NEUROLOGICAL 9 0.0099
99 KOUNIS SYNDROME 22 0.0097
100 DERMATITIS CONTACT 110 0.0096
101 DEVICE USE CONFUSION 5 0.0096
102 BRAIN STEM SYNDROME 7 0.0093
103 CATHETER SITE ERYTHEMA 19 0.0089
104 PERINEAL PAIN 6 0.0084
105 DRUG-DISEASE INTERACTION 6 0.0082
106 DEVICE LOOSENING 7 0.0081
107 CATHETER SITE DISCHARGE 9 0.0080
108 HYPERPHOSPHATAEMIA 17 0.0079
109 SUSPECTED PRODUCT CONTAMINATION 8 0.0079
110 DEVICE OCCLUSION 111 0.0079
111 PRODUCT PACKAGING CONFUSION 19 0.0078
112 CHEMICAL BURN 9 0.0078
113 HAEMOGLOBIN INCREASED 33 0.0072
114 OXYGEN CONSUMPTION INCREASED 17 0.0071
115 TONGUE MOVEMENT DISTURBANCE 6 0.0070
116 DEVICE PLACEMENT ISSUE 25 0.0070
117 OTITIS MEDIA 23 0.0070
118 DEVICE FAILURE 106 0.0070
119 ADJUSTMENT DISORDER 9 0.0069
120 HYPERVOLAEMIA 34 0.0069
121 FOETAL DEATH 35 0.0067
122 ANAESTHETIC COMPLICATION 18 0.0067
123 HYPERURICAEMIA 27 0.0066
124 TONGUE INJURY 6 0.0064
125 POST HERPETIC NEURALGIA 9 0.0063
126 PROCTALGIA 38 0.0059
127 CONSCIOUSNESS FLUCTUATING 6 0.0057
128 DEVICE PHYSICAL PROPERTY ISSUE 44 0.0057
129 PRODUCT LEAKAGE 32 0.0057
130 CATHETER SITE PRURITUS 5 0.0057
131 INCORRECT PRODUCT FORMULATION ADMINISTERED 5 0.0056
132 CATHETER SITE HAEMORRHAGE 14 0.0056
133 GLUCOSE TOLERANCE IMPAIRED 33 0.0056
134 FOREIGN BODY 22 0.0055
135 BLOOD PHOSPHORUS INCREASED 15 0.0055
136 DRUG TITRATION ERROR 14 0.0054
137 ACCIDENTAL DEATH 10 0.0054
138 STRESS CARDIOMYOPATHY 31 0.0053
139 HYPOCHLORAEMIA 6 0.0051
140 TONGUE HAEMORRHAGE 6 0.0051
141 CATHETER SITE PAIN 13 0.0050
142 PRODUCT ADMINISTRATION INTERRUPTED 39 0.0050
143 DEVICE KINK 18 0.0049
144 ANAPHYLACTIC SHOCK 127 0.0049
145 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 16 0.0048
146 SLEEP DEFICIT 10 0.0047
147 THERAPY PARTIAL RESPONDER 73 0.0047
148 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 12 0.0046
149 FACIAL SPASM 5 0.0045
150 MACULAR HOLE 6 0.0045
151 PUPILLARY REFLEX IMPAIRED 8 0.0043
152 JOINT INSTABILITY 6 0.0043
153 OXYGEN THERAPY 7 0.0043
154 INCORRECT DRUG ADMINISTRATION RATE 18 0.0042
155 FOOD INTERACTION 7 0.0040
156 HYPERLIPIDAEMIA 47 0.0039
157 ARTHRITIS BACTERIAL 16 0.0039
158 UNINTENTIONAL MEDICAL DEVICE REMOVAL 45 0.0039
159 PURPURA 34 0.0038
160 LIVE BIRTH 32 0.0038
161 PERSONALITY DISORDER 10 0.0038
162 SUBSTANCE USE DISORDER 12 0.0038
163 THERAPY NON-RESPONDER 168 0.0037
164 LYMPHOCYTE COUNT DECREASED 66 0.0037
165 MATERNAL EXPOSURE TIMING UNSPECIFIED 14 0.0037
166 VITREOUS HAEMORRHAGE 10 0.0036
167 GENERALISED TONIC-CLONIC SEIZURE 59 0.0036
168 IMPAIRED QUALITY OF LIFE 51 0.0035
169 DEVICE INFORMATION OUTPUT ISSUE 27 0.0035
170 PAIN IN JAW 98 0.0035
171 STATUS EPILEPTICUS 39 0.0034
172 PROTEIN TOTAL DECREASED 13 0.0034
173 BILIRUBIN CONJUGATED INCREASED 8 0.0034
174 VENTRICULAR FIBRILLATION 38 0.0034
175 PULSE ABSENT 16 0.0034
176 INJECTION SITE INFECTION 11 0.0033
177 RESPIRATORY ACIDOSIS 13 0.0033
178 VASCULAR DEVICE INFECTION 15 0.0033
179 IMMUNE THROMBOCYTOPENIA 15 0.0033
180 ACCIDENT 39 0.0033
181 BLOOD PRESSURE IMMEASURABLE 5 0.0033
182 SUPRAVENTRICULAR EXTRASYSTOLES 11 0.0033
183 DRUG TOLERANCE DECREASED 9 0.0032
184 HYPOTONIA NEONATAL 5 0.0032
185 RETINAL ARTERY OCCLUSION 8 0.0032
186 HYPERAESTHESIA 26 0.0032
187 DEVICE DISLOCATION 137 0.0031
188 CANCER PAIN 8 0.0031
189 BENIGN PROSTATIC HYPERPLASIA 16 0.0031
190 HYPOALBUMINAEMIA 24 0.0031
191 AUTONOMIC NERVOUS SYSTEM IMBALANCE 9 0.0031
192 CARDIOVASCULAR INSUFFICIENCY 5 0.0031
193 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 8 0.0030
194 MIOSIS 24 0.0030
195 POOR QUALITY SLEEP 64 0.0030
196 PULMONARY ARTERIAL HYPERTENSION 43 0.0030
197 BLOOD SODIUM INCREASED 8 0.0030
198 DEAFNESS BILATERAL 5 0.0029
199 GAZE PALSY 5 0.0029
200 BLOOD PH DECREASED 5 0.0029
201 LACUNAR INFARCTION 7 0.0029
202 CLONUS 8 0.0029
203 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 50 0.0029
204 APNOEA 22 0.0028
205 VOMITING PROJECTILE 8 0.0028
206 PRODUCT CONTAMINATION PHYSICAL 7 0.0028
207 SEASONAL ALLERGY 39 0.0028
208 BLOOD PHOSPHORUS DECREASED 10 0.0027
209 CONDUCTION DISORDER 5 0.0027
210 BLOOD CHLORIDE DECREASED 7 0.0027
211 HYPERCAPNIA 8 0.0027
212 CYSTOID MACULAR OEDEMA 5 0.0027
213 MYDRIASIS 34 0.0026
214 CARDIOGENIC SHOCK 38 0.0026
215 DEVICE USE ERROR 91 0.0026
216 INJECTION SITE INFLAMMATION 13 0.0026
217 DIZZINESS POSTURAL 25 0.0026
218 RESPIRATORY TRACT INFECTION VIRAL 6 0.0026
219 HYPOPHOSPHATAEMIA 19 0.0026
220 PULMONARY HYPERTENSION 53 0.0025
221 SKIN NECROSIS 13 0.0025
222 HYPOCALCAEMIA 47 0.0025
223 OXYGEN SATURATION ABNORMAL 7 0.0025
224 HAEMORRHOIDS 48 0.0025
225 PARAPLEGIA 7 0.0024
226 BLOOD URIC ACID INCREASED 14 0.0024
227 ARTHRITIS INFECTIVE 11 0.0024
228 BUNDLE BRANCH BLOCK LEFT 10 0.0024
229 CARDIAC ARREST 194 0.0023
230 SINUS TACHYCARDIA 33 0.0023
231 BODY TEMPERATURE INCREASED 47 0.0023
232 BLOOD BLISTER 7 0.0022
233 CORNEAL OEDEMA 5 0.0022
234 BONE LESION 8 0.0022
235 SUPRAVENTRICULAR TACHYCARDIA 21 0.0022
236 HYPOXIA 77 0.0022
237 DEAFNESS NEUROSENSORY 7 0.0021
238 HYPERTONIA 12 0.0021
239 BLOOD LACTIC ACID INCREASED 11 0.0021
240 NEUTROPHIL COUNT DECREASED 85 0.0021
241 BRADYCARDIA 110 0.0021
242 FINE MOTOR SKILL DYSFUNCTION 6 0.0021
243 NYSTAGMUS 11 0.0021
244 OXYGEN SATURATION DECREASED 116 0.0021
245 DEVICE LEAKAGE 89 0.0021
246 STRIDOR 6 0.0020
247 IMPAIRED WORK ABILITY 43 0.0020
248 GINGIVAL PAIN 16 0.0020
249 IRON DEFICIENCY 9 0.0020
250 SUSPECTED OFF LABEL USE 9 0.0020
251 PALLOR 53 0.0019
252 TRISMUS 10 0.0019
253 APPENDICITIS 18 0.0019
254 HYPOAESTHESIA ORAL 29 0.0019
255 ORAL HERPES 37 0.0019
256 OBSTRUCTIVE AIRWAYS DISORDER 21 0.0019
257 DYSPNOEA EXERTIONAL 71 0.0019
258 SENSORY LOSS 15 0.0019
259 MYASTHENIA GRAVIS 15 0.0019
260 ANAL ABSCESS 10 0.0019
261 ANAPHYLACTIC REACTION 102 0.0018
262 TOXIC EPIDERMAL NECROLYSIS 28 0.0018
263 HICCUPS 15 0.0018
264 UNRESPONSIVE TO STIMULI 47 0.0018
265 HYPOKALAEMIA 84 0.0018
266 VENTRICULAR TACHYCARDIA 30 0.0018
267 DRUG USE DISORDER 15 0.0018
268 ENDOTRACHEAL INTUBATION 5 0.0018
269 MENINGITIS ASEPTIC 8 0.0018
270 INFUSION SITE EXTRAVASATION 11 0.0018
271 MOTOR DYSFUNCTION 18 0.0018
272 BLOOD ALBUMIN DECREASED 14 0.0018
273 SENSITIVE SKIN 13 0.0018
274 NEUTROPHIL COUNT INCREASED 18 0.0018
275 EYE MOVEMENT DISORDER 12 0.0018
276 HYPOGLYCAEMIC COMA 5 0.0017
277 FEBRILE NEUTROPENIA 115 0.0017
278 LOCALISED OEDEMA 8 0.0017
279 LUMBAR SPINAL STENOSIS 5 0.0017
280 DEVICE ADHESION ISSUE 26 0.0017
281 ARTERIOSCLEROSIS CORONARY ARTERY 11 0.0017
282 GANGRENE 10 0.0017
283 TORSADE DE POINTES 13 0.0017
284 ARTERIAL OCCLUSIVE DISEASE 13 0.0017
285 CRANIOCEREBRAL INJURY 5 0.0017
286 FACIAL PARALYSIS 14 0.0016
287 DYSCHEZIA 5 0.0016
288 WRONG PRODUCT ADMINISTERED 11 0.0016
289 BRAIN NATRIURETIC PEPTIDE INCREASED 5 0.0016
290 BRAIN DEATH 5 0.0016
291 PROTEIN URINE PRESENT 8 0.0016
292 SPINAL OSTEOARTHRITIS 14 0.0016
293 CIRCULATORY COLLAPSE 27 0.0016
294 RIGHT VENTRICULAR FAILURE 11 0.0016
295 CONJUNCTIVITIS 29 0.0016
296 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 8 0.0016
297 HYPERTRIGLYCERIDAEMIA 9 0.0015
298 PNEUMONIA FUNGAL 6 0.0015
299 DEVICE ISSUE 136 0.0015
300 POISONING 19 0.0015
301 RESPIRATORY TRACT CONGESTION 24 0.0015
302 TRICUSPID VALVE INCOMPETENCE 12 0.0015
303 ENDOPHTHALMITIS 9 0.0015
304 SKIN ABRASION 7 0.0015
305 SUBSTANCE ABUSE 12 0.0015
306 LARYNGEAL OEDEMA 9 0.0015
307 SELF-MEDICATION 6 0.0015
308 PARAESTHESIA ORAL 21 0.0015
309 RESPIRATORY ARREST 40 0.0014
310 HEMIPLEGIA 12 0.0014
311 SKIN DISORDER 48 0.0014
312 PROCEDURAL COMPLICATION 11 0.0014
313 CELLULITIS 72 0.0014
314 NEUROTOXICITY 25 0.0014
315 LOW DENSITY LIPOPROTEIN INCREASED 11 0.0014
316 SUDDEN DEATH 15 0.0014
317 HYPERPYREXIA 6 0.0014
318 FIBRIN D DIMER INCREASED 5 0.0014
319 NEUROLOGICAL SYMPTOM 8 0.0014
320 NEURALGIA 34 0.0014
321 ABNORMAL SENSATION IN EYE 6 0.0014
322 MOUTH SWELLING 8 0.0014
323 PRODUCT LABEL CONFUSION 8 0.0014
324 MOUTH HAEMORRHAGE 10 0.0014
325 ACUTE RESPIRATORY FAILURE 26 0.0014
326 WEIGHT FLUCTUATION 14 0.0013
327 GASTROENTERITIS VIRAL 24 0.0013
328 GASTROINTESTINAL MOTILITY DISORDER 7 0.0013
329 BUNDLE BRANCH BLOCK RIGHT 6 0.0013
330 SALIVARY HYPERSECRETION 13 0.0013
331 HEMIPARESIS 22 0.0013
332 NORMAL NEWBORN 7 0.0013
333 MOUTH ULCERATION 27 0.0013
334 DEAFNESS UNILATERAL 7 0.0013
335 CARDIO-RESPIRATORY ARREST 53 0.0013
336 BRONCHOSPASM 18 0.0013
337 INTRACRANIAL PRESSURE INCREASED 7 0.0013
338 NEUTROPHILIA 7 0.0012
339 FULL BLOOD COUNT ABNORMAL 13 0.0012
340 POLYURIA 10 0.0012
341 ANAPHYLACTOID REACTION 5 0.0012
342 DIABETIC NEUROPATHY 6 0.0012
343 HYPOTENSION 243 0.0012
344 PERICARDIAL EFFUSION 28 0.0012
345 ACCIDENTAL OVERDOSE 44 0.0012
346 MULTIPLE ORGAN DYSFUNCTION SYNDROME 34 0.0012
347 LEFT VENTRICULAR DYSFUNCTION 8 0.0012
348 FEELING OF BODY TEMPERATURE CHANGE 7 0.0012
349 PLATELET COUNT DECREASED 127 0.0012
350 SINUS CONGESTION 16 0.0012
351 FLUID RETENTION 60 0.0012
352 BACTERIAL INFECTION 22 0.0012
353 ENDOCARDITIS 6 0.0012
354 LACERATION 11 0.0012
355 NERVE INJURY 13 0.0012
356 DYSARTHRIA 44 0.0012
357 DEVICE MALFUNCTION 82 0.0012
358 ALTERED STATE OF CONSCIOUSNESS 25 0.0012
359 HYPOMAGNESAEMIA 16 0.0011
360 ATELECTASIS 11 0.0011
361 SHOCK 26 0.0011
362 RESPIRATORY RATE INCREASED 10 0.0011
363 ASCITES 33 0.0011
364 QUALITY OF LIFE DECREASED 15 0.0011
365 BONE DENSITY DECREASED 35 0.0011
366 MENTAL STATUS CHANGES 31 0.0011
367 SPINAL PAIN 13 0.0011
368 TACHYPNOEA 15 0.0011
369 INTRAOCULAR PRESSURE INCREASED 14 0.0011
370 BLINDNESS TRANSIENT 8 0.0011
371 EYELID PTOSIS 11 0.0011
372 POOR QUALITY DRUG ADMINISTERED 7 0.0011
373 OEDEMA 58 0.0011
374 RESPIRATORY DEPRESSION 13 0.0011
375 MUSCLE SPASTICITY 13 0.0011
376 EXERCISE TOLERANCE DECREASED 6 0.0010
377 AFFECT LABILITY 10 0.0010
378 HAEMOLYSIS 8 0.0010
379 ENTEROCOCCAL INFECTION 5 0.0010
380 SINUS BRADYCARDIA 10 0.0010
381 DERMATITIS ALLERGIC 13 0.0010
382 RALES 6 0.0010
383 METABOLIC ACIDOSIS 33 0.0010
384 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 8 0.0010
385 MYELOSUPPRESSION 37 0.0010
386 HYPOVOLAEMIA 6 0.0010
387 GROIN PAIN 9 0.0010
388 DRUG ERUPTION 18 0.0010
389 JOINT EFFUSION 7 0.0010
390 SINUS DISORDER 20 0.0010
391 CATARACT 60 0.0010
392 HYPERTRANSAMINASAEMIA 7 0.0010
393 ASPIRATION 11 0.0010
394 HYPERNATRAEMIA 5 0.0010
395 STAPHYLOCOCCAL INFECTION 33 0.0010
396 TOOTHACHE 18 0.0010
397 BLOOD PRESSURE DECREASED 66 0.0010
398 DUODENAL ULCER 7 0.0010
399 INJECTION SITE VESICLES 6 0.0010
400 MIGRAINE 94 0.0010
401 TOXICITY TO VARIOUS AGENTS 166 0.0010
402 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 54 0.0010
403 DEVICE DIFFICULT TO USE 65 0.0010
404 PARALYSIS 14 0.0010
405 HYPONATRAEMIA 55 0.0010
406 CACHEXIA 5 0.0010
407 DEVICE USE ISSUE 17 0.0010
408 MUSCULOSKELETAL CHEST PAIN 15 0.0010
409 SCOLIOSIS 6 0.0010
410 VENTRICULAR EXTRASYSTOLES 10 0.0010
411 HERPES ZOSTER 55 0.0010
412 BRAIN FOG 15 0.0010
413 BLEPHAROSPASM 6 0.0010
414 PHOTOPSIA 6 0.0009
415 PNEUMOTHORAX 15 0.0009
416 RASH MACULO-PAPULAR 21 0.0009
417 ENTERITIS 6 0.0009
418 EPISTAXIS 70 0.0009
419 C-REACTIVE PROTEIN INCREASED 34 0.0009
420 DRUG INTERACTION 148 0.0009
421 WHITE BLOOD CELL COUNT DECREASED 101 0.0009
422 INJECTION SITE DISCHARGE 5 0.0009
423 APHASIA 28 0.0009
424 HAEMODYNAMIC INSTABILITY 7 0.0009
425 LIPASE INCREASED 7 0.0009
426 COLD SWEAT 16 0.0009
427 ATRIOVENTRICULAR BLOCK 7 0.0009
428 PALPITATIONS 106 0.0009
429 ASPARTATE AMINOTRANSFERASE INCREASED 48 0.0009
430 PREMATURE BABY 27 0.0009
431 BLOOD UREA INCREASED 15 0.0009
432 MALNUTRITION 10 0.0009
433 SNEEZING 20 0.0009
434 ACUTE PULMONARY OEDEMA 5 0.0009
435 SLEEP APNOEA SYNDROME 17 0.0009
436 BLOOD CALCIUM DECREASED 10 0.0009
437 ILEUS 11 0.0009
438 BURNING SENSATION 62 0.0009
439 ILLNESS 91 0.0009
440 RENAL CYST 7 0.0009
441 SKIN HAEMORRHAGE 13 0.0009
442 BLISTER 49 0.0009
443 RESPIRATION ABNORMAL 6 0.0009
444 RETINAL DETACHMENT 8 0.0009
445 RESPIRATORY DISTRESS 24 0.0009
446 IRON DEFICIENCY ANAEMIA 8 0.0009
447 GRAND MAL CONVULSION 8 0.0009
448 ENTEROCOLITIS 5 0.0009
449 HYPERVENTILATION 5 0.0009
450 DEPRESSED LEVEL OF CONSCIOUSNESS 34 0.0009
451 TACHYCARDIA 76 0.0009
452 ACUTE RESPIRATORY DISTRESS SYNDROME 15 0.0008
453 CYSTITIS 27 0.0008
454 EATING DISORDER 18 0.0008
455 BACTERAEMIA 10 0.0008
456 EYE INFLAMMATION 8 0.0008
457 SEROTONIN SYNDROME 16 0.0008
458 MEDICATION ERROR 46 0.0008
459 CYANOSIS 13 0.0008
460 RESTLESS LEGS SYNDROME 15 0.0008
461 HAEMOPTYSIS 23 0.0008
462 SEIZURE 95 0.0008
463 PHARYNGEAL SWELLING 8 0.0008
464 ABDOMINAL DISTENSION 85 0.0008
465 VITREOUS FLOATERS 8 0.0008
466 SMALL INTESTINAL OBSTRUCTION 10 0.0008
467 PYELONEPHRITIS 7 0.0008
468 DYSPNOEA 452 0.0008
469 ALANINE AMINOTRANSFERASE INCREASED 49 0.0008
470 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 7 0.0008
471 APHONIA 11 0.0008
472 MUSCULOSKELETAL DISORDER 15 0.0008
473 DISCOMFORT 48 0.0008
474 DRUG LEVEL INCREASED 13 0.0008
475 INCREASED APPETITE 15 0.0008
476 PSYCHOMOTOR HYPERACTIVITY 13 0.0008
477 MUSCLE TWITCHING 18 0.0008
478 DELIRIUM 27 0.0008
479 BRONCHOPULMONARY ASPERGILLOSIS 6 0.0008
480 ANAEMIA 147 0.0008
481 SYNCOPE 77 0.0008
482 HEART RATE INCREASED 76 0.0008
483 MULTIPLE ALLERGIES 6 0.0008
484 PNEUMONIA BACTERIAL 7 0.0008
485 COVID-19 PNEUMONIA 9 0.0008
486 HYPOGAMMAGLOBULINAEMIA 5 0.0008
487 INCONTINENCE 8 0.0008
488 NASAL DISCOMFORT 6 0.0008
489 DRUG INTOLERANCE 73 0.0008
490 CHEST DISCOMFORT 77 0.0008
491 RETCHING 16 0.0007
492 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 53 0.0007
493 HYPOPHAGIA 19 0.0007
494 CHILLS 87 0.0007
495 LOSS OF CONSCIOUSNESS 95 0.0007
496 COLITIS ISCHAEMIC 5 0.0007
497 HYPERGLYCAEMIA 27 0.0007
498 HEADACHE 463 0.0007
499 IMPAIRED GASTRIC EMPTYING 10 0.0007
500 POST PROCEDURAL COMPLICATION 14 0.0007
501 SPINAL COMPRESSION FRACTURE 6 0.0007
502 DROOLING 5 0.0007
503 COORDINATION ABNORMAL 10 0.0007
504 DYSPHAGIA 68 0.0007
505 UPPER RESPIRATORY TRACT INFECTION 33 0.0007
506 OEDEMA PERIPHERAL 87 0.0007
507 HEART RATE DECREASED 25 0.0007
508 BLOOD TEST ABNORMAL 10 0.0007
509 DISSEMINATED INTRAVASCULAR COAGULATION 10 0.0007
510 INFLUENZA 79 0.0007
511 EXPOSURE DURING PREGNANCY 44 0.0007
512 HYPOTONIA 7 0.0007
513 LEUKOPENIA 35 0.0007
514 PSEUDOMONAS INFECTION 6 0.0007
515 LIVER FUNCTION TEST INCREASED 15 0.0007
516 ANGINA PECTORIS 20 0.0007
517 BLOOD MAGNESIUM DECREASED 6 0.0007
518 HIATUS HERNIA 9 0.0007
519 COMA 33 0.0007
520 LIVER INJURY 17 0.0007
521 PULMONARY OEDEMA 31 0.0007
522 TASTE DISORDER 14 0.0007
523 DIARRHOEA 445 0.0007
524 RESPIRATORY SYNCYTIAL VIRUS INFECTION 6 0.0007
525 FLUSHING 70 0.0007
526 ELECTROLYTE IMBALANCE 8 0.0007
527 NECK PAIN 38 0.0007
528 CARDIOTOXICITY 6 0.0007
529 MYOCLONUS 8 0.0007
530 HEPATIC FUNCTION ABNORMAL 25 0.0007
531 HEAVY MENSTRUAL BLEEDING 6 0.0007
532 BLOOD BILIRUBIN INCREASED 18 0.0007
533 VOMITING 313 0.0007
534 CONTUSION 64 0.0007
535 PERIPHERAL SWELLING 102 0.0007
536 OSTEOPENIA 10 0.0007
537 RESPIRATORY FAILURE 48 0.0007
538 PRESYNCOPE 16 0.0007
539 HAEMATOCRIT DECREASED 13 0.0007
540 DIPLOPIA 17 0.0007
541 NAUSEA 516 0.0007
542 CANDIDA INFECTION 11 0.0007
543 CARDIOMEGALY 8 0.0006
544 DEVICE RELATED INFECTION 10 0.0006
545 PRODUCT USE IN UNAPPROVED INDICATION 161 0.0006
546 PRODUCTIVE COUGH 31 0.0006
547 DISTURBANCE IN ATTENTION 35 0.0006
548 DECREASED ACTIVITY 7 0.0006
549 CYTOKINE RELEASE SYNDROME 13 0.0006
550 GENERALISED OEDEMA 8 0.0006
551 BACK PAIN 150 0.0006
552 DIZZINESS 322 0.0006
553 PRODUCT ADMINISTRATION ERROR 13 0.0006
554 CARPAL TUNNEL SYNDROME 9 0.0006
555 SWELLING 60 0.0006
556 ELECTROCARDIOGRAM ABNORMAL 5 0.0006
557 BLOOD SODIUM DECREASED 12 0.0006
558 BLOOD POTASSIUM DECREASED 19 0.0006
559 PAIN IN EXTREMITY 186 0.0006
560 HYPERTENSIVE CRISIS 7 0.0006
561 INJECTION SITE IRRITATION 8 0.0006
562 RESTLESSNESS 23 0.0006
563 THROAT IRRITATION 28 0.0006
564 SKIN INFECTION 7 0.0006
565 GLAUCOMA 12 0.0006
566 SEPTIC SHOCK 27 0.0006
567 EYE INFECTION 7 0.0006
568 RHINORRHOEA 40 0.0006
569 HYPERTENSION 131 0.0006
570 AUTOIMMUNE DISORDER 6 0.0006
571 VITAMIN D DEFICIENCY 6 0.0006
572 ASPHYXIA 5 0.0006
573 RENAL TUBULAR NECROSIS 6 0.0006
574 HEPATOMEGALY 6 0.0006
575 PAIN 375 0.0006
576 ESCHERICHIA INFECTION 5 0.0006
577 TOOTH INFECTION 8 0.0006
578 CYTOMEGALOVIRUS INFECTION 10 0.0006
579 CONSTIPATION 131 0.0006
580 MYALGIA 102 0.0006
581 URINARY RETENTION 20 0.0006
582 EMPHYSEMA 6 0.0006
583 DECREASED APPETITE 138 0.0006
584 TOOTH ABSCESS 6 0.0006
585 SUBARACHNOID HAEMORRHAGE 6 0.0006
586 CHEST PAIN 109 0.0006
587 PNEUMONIA 190 0.0006
588 GINGIVAL BLEEDING 8 0.0006
589 ELECTROCARDIOGRAM QT PROLONGED 21 0.0006
590 MUSCULOSKELETAL DISCOMFORT 10 0.0006
591 GASTROINTESTINAL DISORDER 52 0.0006
592 DRY MOUTH 47 0.0006
593 BURSITIS 7 0.0006
594 RESPIRATORY TRACT INFECTION 15 0.0006
595 PLEURAL EFFUSION 35 0.0006
596 URINARY INCONTINENCE 17 0.0006
597 WHITE BLOOD CELL COUNT INCREASED 22 0.0006
598 MATERNAL EXPOSURE DURING PREGNANCY 51 0.0006
599 VISUAL ACUITY REDUCED 19 0.0006
600 BLOOD CALCIUM INCREASED 5 0.0006
601 BLOOD LACTATE DEHYDROGENASE INCREASED 9 0.0006
602 ABDOMINAL PAIN 132 0.0006
603 OSTEOARTHRITIS 24 0.0006
604 LUNG INFILTRATION 5 0.0006
605 BLOOD TRIGLYCERIDES INCREASED 10 0.0006
606 PREMATURE DELIVERY 9 0.0006
607 ATRIAL FIBRILLATION 55 0.0006
608 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 27 0.0006
609 JOINT INJURY 12 0.0006
610 OSTEOPOROSIS 23 0.0006
611 HYPERSOMNIA 16 0.0006
612 PYREXIA 193 0.0006
613 INTESTINAL OBSTRUCTION 21 0.0006
614 CONFUSIONAL STATE 90 0.0006
615 WHEEZING 33 0.0006
616 ANAL INCONTINENCE 5 0.0006
617 WEIGHT DECREASED 155 0.0006
618 THROAT TIGHTNESS 15 0.0006
619 BRAIN OEDEMA 7 0.0006
620 RASH PRURITIC 30 0.0006
621 MUSCLE ATROPHY 7 0.0006
622 LIMB INJURY 15 0.0006
623 SKIN LACERATION 6 0.0006
624 COMPLICATION ASSOCIATED WITH DEVICE 8 0.0006
625 PELVIC PAIN 10 0.0005
626 OESOPHAGITIS 6 0.0005
627 INTERVERTEBRAL DISC PROTRUSION 12 0.0005
628 PANIC ATTACK 20 0.0005
629 BONE PAIN 32 0.0005
630 GASTROINTESTINAL PAIN 6 0.0005
631 BLOOD PRESSURE INCREASED 83 0.0005
632 FEEDING DISORDER 11 0.0005
633 GAMMA-GLUTAMYLTRANSFERASE INCREASED 12 0.0005
634 DYSKINESIA 22 0.0005
635 TOOTH DISORDER 12 0.0005
636 FEELING COLD 15 0.0005
637 BLOOD CHOLESTEROL INCREASED 25 0.0005
638 BLOOD CREATININE INCREASED 35 0.0005
639 HEPATIC ENCEPHALOPATHY 5 0.0005
640 HAEMORRHAGE INTRACRANIAL 8 0.0005
641 COUGH 150 0.0005
642 OCULAR DISCOMFORT 6 0.0005
643 GASTROOESOPHAGEAL REFLUX DISEASE 43 0.0005
644 FLANK PAIN 5 0.0005
645 ABORTION INDUCED 5 0.0005
646 TREMOR 88 0.0005
647 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 9 0.0005
648 THERAPEUTIC RESPONSE DECREASED 32 0.0005
649 SINUSITIS 54 0.0005
650 EAR INFECTION 14 0.0005
651 VERTIGO 32 0.0005
652 NEOPLASM 6 0.0005
653 FEELING ABNORMAL 125 0.0005
654 ANXIETY 148 0.0005
655 CHOLELITHIASIS 17 0.0005
656 WEIGHT INCREASED 116 0.0005
657 RASH MACULAR 18 0.0005
658 PRODUCT USE ISSUE 96 0.0005
659 INFLUENZA LIKE ILLNESS 42 0.0005
660 FUNGAL INFECTION 17 0.0005
661 FATIGUE 394 0.0005
662 INSOMNIA 134 0.0005
663 ULCER 8 0.0005
664 SCIATICA 8 0.0005
665 GOUT 9 0.0005
666 ERYTHEMA 103 0.0005
667 MASS 7 0.0005
668 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 26 0.0005
669 THROMBOSIS 40 0.0005
670 EYE PAIN 28 0.0005
671 FULL BLOOD COUNT DECREASED 10 0.0005
672 OFF LABEL USE 434 0.0005
673 BONE DISORDER 9 0.0005
674 DEVICE BREAKAGE 20 0.0005
675 CYTOPENIA 6 0.0005
676 SUBDURAL HAEMATOMA 7 0.0005
677 METASTASES TO BONE 8 0.0005
678 EAR DISCOMFORT 5 0.0005
679 PRODUCT PREPARATION ERROR 10 0.0005
680 OVERDOSE 105 0.0005
681 HYPERCALCAEMIA 6 0.0005
682 ARRHYTHMIA 23 0.0005
683 LIMB DISCOMFORT 15 0.0005
684 PHARYNGITIS 6 0.0005
685 BLOOD ALKALINE PHOSPHATASE INCREASED 12 0.0005
686 ARTHRITIS 38 0.0005
687 HYPOKINESIA 7 0.0005
688 HYPERHIDROSIS 62 0.0005
689 HYPOAESTHESIA 72 0.0005
690 LIP SWELLING 16 0.0005
691 DISORIENTATION 19 0.0005
692 SECRETION DISCHARGE 6 0.0005
693 STOMATITIS 29 0.0005
694 PNEUMONITIS 13 0.0005
695 NASOPHARYNGITIS 88 0.0005
696 NASAL CONGESTION 28 0.0005
697 SEPSIS 53 0.0005
698 PULMONARY MASS 7 0.0005
699 PROCEDURAL PAIN 13 0.0005
700 WOUND 13 0.0005
701 CARDIAC FAILURE 37 0.0005
702 PLATELET COUNT INCREASED 6 0.0005
703 BACK INJURY 5 0.0005
704 HYPERSENSITIVITY 85 0.0005
705 MUSCULAR WEAKNESS 52 0.0005
706 DYSPEPSIA 45 0.0005
707 TINNITUS 21 0.0005
708 INTENTIONAL PRODUCT MISUSE 40 0.0005
709 INFECTION 66 0.0005
710 ORAL CANDIDIASIS 6 0.0005
711 PHARYNGEAL OEDEMA 7 0.0005
712 WITHDRAWAL SYNDROME 19 0.0005
713 HEAD DISCOMFORT 8 0.0005
714 EXPIRED PRODUCT ADMINISTERED 15 0.0005
715 LUNG INFECTION 7 0.0005
716 EYE HAEMORRHAGE 6 0.0004
717 NEEDLE ISSUE 13 0.0004
718 DRUG ABUSE 37 0.0004
719 SYNOVITIS 8 0.0004
720 DRUG TOXICITY 6 0.0004
721 MALAISE 193 0.0004
722 PERIPHERAL COLDNESS 6 0.0004
723 ABDOMINAL DISCOMFORT 73 0.0004
724 DYSURIA 16 0.0004
725 MUSCLE TIGHTNESS 7 0.0004
726 ORAL DISCOMFORT 6 0.0004
727 CONTRAINDICATED PRODUCT ADMINISTERED 13 0.0004
728 HAEMOGLOBIN DECREASED 44 0.0004
729 ASTHMA 48 0.0004
730 FEELING HOT 26 0.0004
731 ASTHENIA 159 0.0004
732 ATAXIA 5 0.0004
733 GASTRIC ULCER 8 0.0004
734 VIRAL INFECTION 14 0.0004
735 TREATMENT NONCOMPLIANCE 23 0.0004
736 MUCOSAL INFLAMMATION 11 0.0004
737 PRODUCT ADHESION ISSUE 15 0.0004
738 NEUTROPENIA 57 0.0004
739 GASTROINTESTINAL HAEMORRHAGE 35 0.0004
740 CONDITION AGGRAVATED 127 0.0004
741 ARTHRALGIA 173 0.0004
742 SOMNOLENCE 83 0.0004
743 ADRENAL INSUFFICIENCY 5 0.0004
744 BLOOD PRESSURE SYSTOLIC INCREASED 8 0.0004
745 FEAR 11 0.0004
746 HAEMATURIA 14 0.0004
747 APPLICATION SITE PAIN 9 0.0004
748 AGITATION 30 0.0004
749 ENCEPHALOPATHY 10 0.0004
750 ACUTE MYOCARDIAL INFARCTION 12 0.0004
751 GLOMERULAR FILTRATION RATE DECREASED 5 0.0004
752 STEVENS-JOHNSON SYNDROME 9 0.0004
753 OSTEONECROSIS OF JAW 10 0.0004
754 NIGHT SWEATS 13 0.0004
755 BLOOD PRESSURE ABNORMAL 8 0.0004
756 ORAL PAIN 9 0.0004
757 RESPIRATORY DISORDER 12 0.0004
758 OROPHARYNGEAL PAIN 37 0.0004
759 EOSINOPHILIA 7 0.0004
760 URINARY TRACT INFECTION 68 0.0004
761 JOINT SWELLING 48 0.0004
762 LYMPHADENOPATHY 14 0.0004
763 BONE MARROW FAILURE 8 0.0004
764 INSURANCE ISSUE 6 0.0004
765 DEHYDRATION 52 0.0004
766 NEUROPATHY PERIPHERAL 37 0.0004
767 LUNG DISORDER 19 0.0004
768 EXPOSURE VIA SKIN CONTACT 10 0.0004
769 RED BLOOD CELL COUNT DECREASED 11 0.0004
770 SPEECH DISORDER 20 0.0004
771 IMMUNE SYSTEM DISORDER 5 0.0004
772 HEAD INJURY 12 0.0004
773 HALLUCINATION, VISUAL 8 0.0004
774 DEPRESSED MOOD 20 0.0004
775 BRONCHITIS 28 0.0004
776 PRODUCT PRESCRIBING ERROR 9 0.0004
777 HALLUCINATION, AUDITORY 6 0.0004
778 ADVERSE REACTION 5 0.0004
779 COVID-19 66 0.0004
780 DYSPHONIA 22 0.0004
781 ABSCESS 6 0.0004
782 HEPATIC STEATOSIS 7 0.0004
783 PARAESTHESIA 59 0.0004
784 SENSORY DISTURBANCE 6 0.0004
785 HEPATIC CIRRHOSIS 7 0.0004
786 LOCALISED INFECTION 9 0.0004
787 HYPOACUSIS 16 0.0004
788 DRUG INEFFECTIVE 488 0.0004
789 URTICARIA 62 0.0004
790 SKIN DISCOLOURATION 17 0.0004
791 BLOOD POTASSIUM INCREASED 6 0.0004
792 PRODUCT DISPENSING ERROR 8 0.0004
793 ACUTE KIDNEY INJURY 56 0.0004
794 ERUCTATION 7 0.0004
795 ANGIOEDEMA 16 0.0004
796 DYSTONIA 7 0.0004
797 RASH PAPULAR 8 0.0004
798 UPPER GASTROINTESTINAL HAEMORRHAGE 6 0.0004
799 RASH ERYTHEMATOUS 17 0.0004
800 ABNORMAL BEHAVIOUR 14 0.0004
801 FALL 117 0.0004
802 SCAR 6 0.0004
803 ACCIDENTAL EXPOSURE TO PRODUCT 36 0.0003
804 MOBILITY DECREASED 25 0.0003
805 LETHARGY 20 0.0003
806 PULMONARY EMBOLISM 33 0.0003
807 EXTRA DOSE ADMINISTERED 14 0.0003
808 HYPERTHYROIDISM 5 0.0003
809 MENTAL DISORDER 15 0.0003
810 BLINDNESS 14 0.0003
811 MUSCLE SPASMS 63 0.0003
812 COGNITIVE DISORDER 16 0.0003
813 INTENTIONAL PRODUCT USE ISSUE 30 0.0003
814 VISION BLURRED 47 0.0003
815 HYPERKALAEMIA 12 0.0003
816 GASTRITIS 9 0.0003
817 DIABETES MELLITUS 26 0.0003
818 SLEEP DISORDER 24 0.0003
819 DIABETES MELLITUS INADEQUATE CONTROL 6 0.0003
820 GALLBLADDER DISORDER 6 0.0003
821 RHABDOMYOLYSIS 14 0.0003
822 IMMUNODEFICIENCY 5 0.0003
823 VISUAL IMPAIRMENT 41 0.0003
824 RASH 144 0.0003
825 ABDOMINAL PAIN UPPER 68 0.0003
826 CRYING 12 0.0003
827 END STAGE RENAL DISEASE 6 0.0003
828 INJECTION SITE PAIN 100 0.0003
829 INCORRECT PRODUCT ADMINISTRATION DURATION 7 0.0003
830 ANKLE FRACTURE 5 0.0003
831 THROMBOCYTOPENIA 36 0.0003
832 DELUSION 5 0.0003
833 PRODUCT PRESCRIBING ISSUE 7 0.0003
834 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 15 0.0003
835 SWOLLEN TONGUE 10 0.0003
836 INJECTION SITE REACTION 22 0.0003
837 PHOTOPHOBIA 6 0.0003
838 HOT FLUSH 24 0.0003
839 FOOT FRACTURE 6 0.0003
840 HAEMATEMESIS 8 0.0003
841 TRANSAMINASES INCREASED 7 0.0003
842 PRODUCT DOSE OMISSION ISSUE 92 0.0003
843 BLOOD CREATINE PHOSPHOKINASE INCREASED 9 0.0003
844 PANCREATITIS ACUTE 7 0.0003
845 CHROMATURIA 7 0.0003
846 CARDIAC DISORDER 29 0.0003
847 INTERSTITIAL LUNG DISEASE 15 0.0003
848 HEART RATE IRREGULAR 7 0.0003
849 SKIN ULCER 8 0.0003
850 EAR PAIN 6 0.0003
851 BACK DISORDER 5 0.0003
852 AMNESIA 20 0.0003
853 SEDATION 8 0.0003
854 LABORATORY TEST ABNORMAL 9 0.0003
855 PSYCHOTIC DISORDER 9 0.0003
856 ANHEDONIA 8 0.0003
857 PANCYTOPENIA 17 0.0003
858 IRRITABILITY 18 0.0003
859 HEPATIC FAILURE 9 0.0003
860 MUSCULOSKELETAL STIFFNESS 26 0.0003
861 TRANSIENT ISCHAEMIC ATTACK 10 0.0003
862 GAIT DISTURBANCE 56 0.0003
863 DEVICE DELIVERY SYSTEM ISSUE 8 0.0003
864 RIB FRACTURE 6 0.0003
865 PRURITUS 111 0.0003
866 NERVOUS SYSTEM DISORDER 9 0.0003
867 FIBROMYALGIA 7 0.0003
868 NERVOUSNESS 15 0.0003
869 HAEMORRHAGE 30 0.0003
870 CEREBRAL INFARCTION 7 0.0003
871 GENERAL PHYSICAL HEALTH DETERIORATION 33 0.0003
872 INJURY 20 0.0003
873 EMOTIONAL DISTRESS 34 0.0003
874 HIP FRACTURE 9 0.0003
875 IRRITABLE BOWEL SYNDROME 6 0.0003
876 CONVULSION 16 0.0003
877 INCORRECT ROUTE OF DRUG ADMINISTRATION 10 0.0003
878 HALLUCINATION 21 0.0003
879 GLYCOSYLATED HAEMOGLOBIN INCREASED 7 0.0003
880 LEUKOCYTOSIS 5 0.0003
881 CLOSTRIDIUM DIFFICILE INFECTION 6 0.0003
882 MELAENA 6 0.0003
883 LIVER DISORDER 12 0.0003
884 GAIT INABILITY 9 0.0003
885 AGRANULOCYTOSIS 5 0.0003
886 THERAPEUTIC PRODUCT EFFECT DECREASED 12 0.0003
887 DEAFNESS 7 0.0003
888 TYPE 2 DIABETES MELLITUS 9 0.0003
889 APPLICATION SITE ERYTHEMA 7 0.0003
890 TREATMENT FAILURE 22 0.0003
891 LACRIMATION INCREASED 8 0.0003
892 BLOOD URINE PRESENT 5 0.0003
893 EPILEPSY 8 0.0003
894 SKIN EXFOLIATION 22 0.0003
895 LOWER LIMB FRACTURE 5 0.0003
896 DEPRESSION 59 0.0003
897 DRUG-INDUCED LIVER INJURY 8 0.0003
898 BALANCE DISORDER 22 0.0003
899 SYSTEMIC LUPUS ERYTHEMATOSUS 9 0.0003
900 INFLAMMATION 13 0.0003
901 PRODUCT QUALITY ISSUE 34 0.0003
902 BLOOD PRESSURE FLUCTUATION 6 0.0002
903 DIABETIC KETOACIDOSIS 6 0.0002
904 INJECTION SITE SWELLING 19 0.0002
905 MEMORY IMPAIRMENT 34 0.0002
906 PANCREATITIS 13 0.0002
907 THERAPEUTIC RESPONSE UNEXPECTED 11 0.0002
908 IMPAIRED HEALING 8 0.0002
909 EYE IRRITATION 14 0.0002
910 INJECTION SITE WARMTH 5 0.0002
911 CEREBROVASCULAR ACCIDENT 41 0.0002
912 LIVER FUNCTION TEST ABNORMAL 7 0.0002
913 PNEUMONIA ASPIRATION 6 0.0002
914 NEPHROLITHIASIS 11 0.0002
915 RENAL IMPAIRMENT 20 0.0002
916 RENAL DISORDER 11 0.0002
917 FOETAL EXPOSURE DURING PREGNANCY 19 0.0002
918 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 6 0.0002
919 RECTAL HAEMORRHAGE 10 0.0002
920 HAEMATOMA 6 0.0002
921 NEOPLASM PROGRESSION 8 0.0002
922 BLOOD GLUCOSE DECREASED 11 0.0002
923 RENAL FAILURE 30 0.0002
924 HYPOTHYROIDISM 7 0.0002
925 MOVEMENT DISORDER 7 0.0002
926 INJECTION SITE ERYTHEMA 27 0.0002
927 HAEMATOCHEZIA 12 0.0002
928 ARTHROPATHY 12 0.0002
929 ROAD TRAFFIC ACCIDENT 9 0.0002
930 DEMENTIA 6 0.0002
931 EYE DISORDER 7 0.0002
932 INJECTION SITE HAEMORRHAGE 17 0.0002
933 COLITIS 8 0.0002
934 CHRONIC KIDNEY DISEASE 16 0.0002
935 INTERNATIONAL NORMALISED RATIO INCREASED 6 0.0002
936 ECZEMA 11 0.0002
937 BLOOD GLUCOSE INCREASED 39 0.0002
938 HYPOGLYCAEMIA 10 0.0002
939 MALIGNANT NEOPLASM PROGRESSION 21 0.0002
940 INJECTION SITE BRUISING 16 0.0002
941 DRY EYE 10 0.0002
942 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 36 0.0002
943 SWELLING FACE 13 0.0002
944 CARDIAC FAILURE CONGESTIVE 16 0.0002
945 CARDIOVASCULAR DISORDER 5 0.0002
946 ADVERSE EVENT 18 0.0002
947 FEMUR FRACTURE 6 0.0002
948 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 39 0.0002
949 MUSCULOSKELETAL PAIN 10 0.0002
950 OCULAR HYPERAEMIA 9 0.0002
951 DYSGEUSIA 14 0.0002
952 EYE SWELLING 7 0.0002
953 DEEP VEIN THROMBOSIS 12 0.0002
954 VAGINAL HAEMORRHAGE 8 0.0002
955 HOSPITALISATION 28 0.0002
956 FLATULENCE 10 0.0002
957 RHEUMATOID ARTHRITIS 20 0.0002
958 UNEVALUABLE EVENT 13 0.0002
959 INCORRECT DOSE ADMINISTERED 38 0.0002
960 INJECTION SITE MASS 6 0.0002
961 HEPATIC ENZYME INCREASED 11 0.0002
962 COLITIS ULCERATIVE 7 0.0002
963 THERAPY INTERRUPTED 11 0.0002
964 SKIN BURNING SENSATION 11 0.0002
965 SURGERY 9 0.0002
966 SUICIDAL IDEATION 14 0.0002
967 SKIN IRRITATION 7 0.0002
968 INFUSION RELATED REACTION 10 0.0002
969 EYE PRURITUS 5 0.0001
970 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 5 0.0001
971 ADVERSE DRUG REACTION 13 0.0001
972 POLLAKIURIA 6 0.0001
973 RENAL FAILURE ACUTE 6 0.0001
974 DEATH 120 0.0001
975 NEOPLASM MALIGNANT 9 0.0001
976 INJECTION SITE PRURITUS 9 0.0001
977 SUICIDE ATTEMPT 8 0.0001
978 LOWER RESPIRATORY TRACT INFECTION 6 0.0001
979 ALOPECIA 25 0.0001
980 DISEASE PROGRESSION 14 0.0001
981 PSORIASIS 14 0.0001
982 DISEASE RECURRENCE 5 0.0001
983 BREAST CANCER 9 0.0001
984 COMPLETED SUICIDE 8 0.0001
985 DRUG EFFECT DECREASED 5 0.0001
986 DRY SKIN 12 0.0001
987 MYOCARDIAL INFARCTION 14 0.0001
988 PRODUCT STORAGE ERROR 7 0.0001
989 INTENTIONAL OVERDOSE 5 0.0001
990 DRUG DEPENDENCE 11 0.0001
991 ACNE 5 0.0001
992 NO ADVERSE EVENT 11 0.0001